tiprankstipranks
Protect Pharmaceutical Corporation (PRTT)
OTHER OTC:PRTT
US Market
PRTT
Protect Pharmaceutical
RESEARCH TOOLSreports
Want to see PRTT full AI Analyst Report?

Protect Pharmaceutical (PRTT) Income Statement

17 Followers

Protect Pharmaceutical Income Statement

Last quarter (Q2 2025), Protect Pharmaceutical's total revenue was $26.34M, a decrease of -42.05% from the same quarter last year. In Q2, Protect Pharmaceutical's net income was $6.63M. See Protect Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 132.26M$ 136.16M$ 81.80M$ 78.79M$ 5.94M
Gross Profit
$ 72.56M$ 73.31M$ 41.58M$ 44.37M$ 5.86M
Operating Expenses
$ 14.92M$ 25.77M$ 16.32M$ 16.49M$ 48.11K
Depreciation and Amortization
$ 0.00$ 167.90K$ 228.49K$ 236.56K$ 206.30K
EBITDA
$ 57.64M$ 47.71M$ 25.49M$ 28.11M$ 5.81M
Operating Income
$ 57.64M$ 47.54M$ 25.26M$ 27.88M$ 5.81M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.37K
Pretax Income
$ 57.64M$ 47.54M$ 25.26M$ 27.88M$ 5.81M
Net Income
$ 56.33M$ 45.91M$ 22.44M$ 20.21M$ 5.81M
Per Share Metrics
Basic EPS
$ 0.98$ 0.80$ 0.43$ 0.36$ 0.11
Diluted EPS
$ 0.98$ 0.80$ 0.43$ 0.36$ 0.11
Weighted Average Shares Outstanding
 57.45M 57.45M 52.78M 56.25M 54.95M
Weighted Average Shares Outstanding (Diluted)
 57.45M 57.45M 52.78M 56.25M 54.95M
Currency in USD

Protect Pharmaceutical Earnings and Revenue History